OpenURL Connection Search

Select item for more details and to access through your institution.

Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium‐glucose cotransporter‐2 inhibitor and glucagon‐like peptide‐1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease
Published in:
Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3248, doi. 10.1111/dom.15652
By:
- Tsukamoto, Shunichiro;
- Kobayashi, Kazuo;
- Toyoda, Masao;
- Tone, Atsuhito;
- Kawanami, Daiji;
- Suzuki, Daisuke;
- Tsuriya, Daisuke;
- Machimura, Hideo;
- Shimura, Hidetoshi;
- Wakui, Hiromichi;
- Takeda, Hiroshi;
- Yokomizo, Hisashi;
- Takeshita, Kei;
- Chin, Keiichi;
- Kanasaki, Keizo;
- Miyauchi, Masaaki;
- Saburi, Masuo;
- Morita, Miwa;
- Yomota, Miwako;
- Kimura, Moritsugu
Publication type:
Article
Pretreatment body mass index affects achievement of target blood pressure with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease.
Published in:
Hypertension Research, 2024, v. 47, n. 3, p. 628, doi. 10.1038/s41440-023-01464-y
By:
- Tsukamoto, Shunichiro;
- Kobayashi, Kazuo;
- Toyoda, Masao;
- Hatori, Nobuo;
- Kanaoka, Tomohiko;
- Wakui, Hiromichi;
- Sakai, Hiroyuki;
- Furuki, Takayuki;
- Chin, Keiichi;
- Ito, Shun;
- Suzuki, Daisuke;
- Umezono, Tomoya;
- Aoyama, Togo;
- Nakajima, Shinichi;
- Hishiki, Toshimasa;
- Hatori, Yutaka;
- Hayashi, Masahiro;
- Shimura, Hidetoshi;
- Minagawa, Fuyuki;
- Mokubo, Atsuko
Publication type:
Article
Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medication.
Published in:
Diabetes & Vascular Disease Research, 2023, v. 20, n. 6, p. 1, doi. 10.1177/14791641231222837
By:
- Kobayashi, Kazuo;
- Toyoda, Masao;
- Tone, Atsuhito;
- Kawanami, Daiji;
- Suzuki, Daisuke;
- Tsuriya, Daisuke;
- Machimura, Hideo;
- Shimura, Hidetoshi;
- Takeda, Hiroshi;
- Yokomizo, Hisashi;
- Takeshita, Kei;
- Chin, Keiichi;
- Kanasaki, Keizo;
- Miyauchi, Masaaki;
- Saburi, Masuo;
- Morita, Miwa;
- Yomota, Miwako;
- Kimura, Moritsugu;
- Hatori, Nobuo;
- Nakajima, Shinichi
Publication type:
Article
Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP study.
Published in:
Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1358573
By:
- Yoshimi Muta;
- Kazuo Kobayashi;
- Masao Toyoda;
- Atsuhito Tone;
- Daisuke Suzuki;
- Daisuke Tsuriya;
- Hideo Machimura;
- Hidetoshi Shimura;
- Hiroshi Takeda;
- Hisashi Yokomizo;
- Kei Takeshita;
- Keiichi Chin;
- Keizo Kanasaki;
- Kouichi Tamura;
- Masaaki Miyauchi;
- Masuo Saburi;
- Miwa Morita;
- Miwako Yomota;
- Moritsugu Kimura;
- Nobuo Hatori
Publication type:
Article

Found: 4

Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium‐glucose cotransporter‐2 inhibitor and glucagon‐like peptide‐1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease

Pretreatment body mass index affects achievement of target blood pressure with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease.

Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medication.

Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP study.